Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Retained Earnings (2023 - 2025)

Baird Medical Investment Holdings has reported Retained Earnings over the past 3 years, most recently at -$1.4 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 105.13% year-over-year to -$1.4 million; the TTM value through Dec 2025 reached -$1.4 million, down 105.13%, while the annual FY2025 figure was -$1.4 million, 105.13% down from the prior year.
  • Retained Earnings for Q4 2025 was -$1.4 million at Baird Medical Investment Holdings, up from -$2.2 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $26.8 million in Q4 2024 and troughed at -$2.2 million in Q2 2025.
  • A 3-year average of $5.3 million and a median of -$1.7 million in 2023 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: soared 1434.82% in 2024 and later tumbled 105.13% in 2025.
  • Year by year, Retained Earnings stood at -$2.0 million in 2023, then soared by 1434.82% to $26.8 million in 2024, then tumbled by 105.13% to -$1.4 million in 2025.
  • Business Quant data shows Retained Earnings for BDMD at -$1.4 million in Q4 2025, -$2.2 million in Q2 2025, and $26.8 million in Q4 2024.